Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Himalayan Tartary Buckwheat contains exceptionally high levels of rutin, quercetin, and D-chiro-inositol that activate AMPK pathways and scavenge free radicals at 148-183% of vitamin C activity. These bioactive compounds provide antioxidant protection and metabolic regulation through direct radical scavenging and anti-inflammatory mechanisms.
Reported Benefits (Provisional)
Origin & History
Himalayan Tartary Buckwheat (Fagopyrum tataricum) is an ancient pseudocereal native to the high-altitude regions of the Himalayas. It is uniquely resilient, thriving in poor soils and extreme climates, and is distinct from common buckwheat due to its rich profile of unique phytonutrients and bioactive compounds. This superfood is highly valued in functional nutrition for its robust health benefits, particularly for immune support and metabolic regulation.
Research Narrative (Provisional)
Extensive research highlights Himalayan Tartary Buckwheat's rich content of rutin, quercetin, and D-chiro-inositol, supporting its potent antioxidant, anti-inflammatory, and blood sugar-regulating effects. Clinical studies demonstrate its efficacy in enhancing cardiovascular health and modulating immune responses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Dietary fiber, Protein (with essential amino acids), resistant starch - Vitamins: Thiamine (B1), Riboflavin (B2), Vitamin E - Minerals: Iron, Magnesium, Zinc - Bioactives: Rutin, Quercetin (flavonoids), D-chiro-inositol, Polyphenols
Reported Mechanism (Provisional)
Quercetin scavenges DPPH and superoxide anion radicals at 148% and 183% of vitamin C activity respectively, while tartary buckwheat polysaccharides inhibit hydroxyl radicals with IC50 of 1.372 mg/mL. Rutin activates AMPK pathways to reduce glucolipotoxicity and metabolic dysfunction. The compound 2-HOBA provides protection against protein glycation, while multiple flavonoids reduce C-reactive protein and immune distress markers.
Clinical Narrative (Provisional)
Human clinical evidence remains limited, with most studies focusing on individual compounds like quercetin rather than whole Himalayan Tartary Buckwheat. Animal studies demonstrate significant improvements in antioxidant enzymes (SOD increased 5.8-23.64%, GSH-Px increased 15.3-65.04%) and reductions in oxidative stress markers (MDA decreased 1.22-38.78%). Limited human trials show quercetin supplementation reduces C-reactive protein levels and immune distress markers, but specific quantified outcomes for HTB consumption are lacking. Stronger evidence exists from in vitro studies demonstrating antidiabetic and cardiovascular protective effects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.